Federated Hermes
PASG icon

Federated Hermes’s Passage Bio PASG Stock Holding History

Federated Hermes’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-39
Closed -$548 – 2161
2024
Q3 		$548 Hold
39
– – ﹤0.01% 1995
2024
Q2 		$622 Hold
39
– – ﹤0.01% 1961
2024
Q1 		$1.06K Buy
+39
New +$938 ﹤0.01% 1960
2023
Q4 		– Sell
-26
Closed -$336 – 2165
2023
Q3 		$336 Sell
26
-57
-69% -$936 ﹤0.01% 2056
2023
Q2 		$1.55K Sell
83
-81
-49% -$1.6K ﹤0.01% 2004
2023
Q1 		$3.14K Sell
164
-121
-42% -$3.28K ﹤0.01% 1974
2022
Q4 		$7.86K Buy
285
+93
+48% +$2.35K ﹤0.01% 1893
2022
Q3 		$5K Sell
192
-155
-45% -$6.11K ﹤0.01% 1892
2022
Q2 		$16K Sell
347
-129
-27% -$6.03K ﹤0.01% 1790
2022
Q1 		$29K Buy
476
+471
+9,420% +$38.8K ﹤0.01% 1794
2021
Q4 		$1K Buy
+5
New +$817 ﹤0.01% 2136
2020
Q2 		– Sell
-2,000
Closed -$630K – 2342
2020
Q1 		$630K Buy
+2,000
New +$626K ﹤0.01% 1309

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes's PASG Position: Q4 2024 in Review

Federated Hermes sold out of Passage Bio (PASG) in Q4 2024, closing a stake of 39 shares — an estimated $548 sold.

Federated Hermes first reported a position in PASG in Q1 2020 and held it in 12 quarters. The position peaked at $630K in Q1 2020. 44 funds tracked by Wall St. Rank hold PASG as of Q4 2024.

  • Federated Hermes reported no remaining Passage Bio position as of Q4 2024 after selling out during the quarter.
  • Federated Hermes sold 39 Passage Bio shares in Q4 2024, an estimated $548.
  • Federated Hermes first reported a position in Passage Bio in Q1 2020 and held it in 12 quarters.
  • Federated Hermes's Passage Bio position peaked at $630K in Q1 2020.
  • 44 funds tracked by Wall St. Rank held Passage Bio as of Q4 2024.

Based on Federated Hermes's 13F filing for Q4 2024, filed 13 Feb 2025.